October 13th, 2015

Body, Mind, Soul, Spirit

The Human Energy Crisis: 9 Women’s Secrets to Balancing Work, Life, Family and Fitness

Body, Mind, Soul, Spirit

At this very moment, you could be facing a pervasive, invasive problem that is preventing you from being your personal and professional best. It’s a problem that many women – from business professionals to new moms – share.

The Johnson & Johnson Human Performance Institute (HPI) calls it the Human Energy Crisis. It’s a result of ever-growing demands on our time, our bodies and our energy. In a world where we’re expected to perform 24/7, the pressure is not only daunting, it can be debilitating. And when we attempt to expend more energy than we have, our businesses, our bodies and our home lives suffer.

What’s a beyond busy woman to do?

As sponsors of the 2015 Fortune The Most Powerful Women summit – at which HPI’s Manager of Client Training, Jennifer Lea, will be taking the stage, we at Johnson & Johnson took the opportunity to ask her, as well as a host of busy female J&J executives, to share what they know about hacking what we call “energy management.”

Why Time Is Not the Answer

There’s a reason people say, “If only there were more hours in the day.” When faced with a crisis (or two), our gut reaction is to stay up later, get up earlier, figure out a way to squeeze every last drop out of our day.

Read More

October 12th, 2015

8 Ways Johnson & Johnson Helps Women Advance

Sandi Peterson is the Johnson & Johnson Group Worldwide Chairman and a 2015 Fortune Most Powerful Woman. We salute both Sandi’s leadership and the example she sets for empowering women.  Advancing women – whether it’s ensuring access to critical health care or having opportunities in the workplace – is at the heart of many of Johnson & Johnson’s programs and initiatives around the world. Below, we shine a spotlight on some of the ways that Johnson & Johnson has been helping to empower women for over a century – and how we’ll continue to do so for generations to come.

empowering women


RELATED: 7 Questions for Sandi Peterson

RELATED: 7 Ways Healthcare Could Be Different for Generation Z


Read More

October 12th, 2015

7 Questions for Sandi Peterson, J&J Group Worldwide Chairman & Fortune Most Powerful Woman

Sandi Peterson
Sandi Peterson is the Johnson & Johnson Group Worldwide Chairman and a 2015 Fortune Most Powerful Woman. She will be taking the stage at the Fortune The Most Powerful Women summit this year. Not only is she a powerful leader, she’s a devoted mentor, with tips to share with other women looking to follow in her footsteps.

This year’s theme at the Fortune Most Powerful Women Conference is “Leading with Purpose.” How do you lead with purpose?
Professionally, leading with purpose equates to listening. I think you really have to listen to your people – the challenges and issues they’re facing, the opportunities they see ahead and everything in between. It’s about taking the journey with your people so that you can lead them effectively, and in a way that really connects with them in the head and the heart.

I think it also means being the kind of leader who is not afraid to motivate and positively push the people you lead beyond the limits of what they thought they could do, to discover new personal bests for themselves and for the business. I try to live my personal life in much the same way. I watch and listen to others as much as possible.

Read More

October 12th, 2015

7 Ways Health Care Could Be Different for Generation Z

This year, for the second time, Sandi Peterson, Johnson & Johnson Group Worldwide Chairman, was named to Fortune’s Most Powerful Women list. At the 2015 The Most Powerful Women summit in Washington D.C., she will take the stage to talk about global risk and opportunity and J&J’s ongoing commitment to advancing health care innovation around the world. Below, just a few ways it could impact the health of the next generation.

  1. Robots in the operating roomYou’ll expect to have a robot in the operating room.

What role will a robot play in the OR of the future? Robotic-assisted surgery is a type of minimally invasive surgery that uses technology to give surgeons greater control, access and accuracy during a procedure, while benefitting patients by minimizing trauma and scarring and enabling accelerated healing.

This March, Johnson & Johnson announced that Ethicon, a medical device company within the Johnson & Johnson family of companies, had signed an agreement to enter into a strategic collaboration with Google, Inc., working with the Life Sciences team on advancing surgical robotics to benefit surgeons, patients and health care systems.

“This collaboration with Google is another important step in our commitment to advancing surgical care, and together, we aim to put the best science, technology and surgical know-how in the hands of medical teams around the world,” said Gary Pruden, Worldwide Chairman, Johnson & Johnson Medical Devices.

Read More

October 11th, 2015

Janssen Recognizes World Arthritis Day

Today, October 12th, the Janssen Pharmaceutical Companies of Johnson & Johnson stand with the European League Against Rheumatism in support of World Arthritis Day, an annual event to raise awareness of rheumatic and musculoskeletal diseases.

At Janssen, we understand the impact that conditions like rheumatoid arthritis (RA), psoriatic arthritis and ankylosing spondylitis have each and every day on patients and their loved ones. For the past twenty years, we have made it our mission to address these challenges through the development of advanced biologic therapies. While these important medicines have changed the way these diseases are treated, we still strive to do for more patients.

Today, our scientists are advancing the latest research to discover and develop the next generation of medicines that will provide new, more personalized approaches in addressing individual patient needs. We look to the future, motivated by the successes we have seen over the years, and inspired by the challenges we recognize still exist for many people living with the pain, inflammation and limitations associated with rheumatic diseases.

As we look to the future, we envision #aworldfreefrom immune and inflammatory diseases like RA. That’s our vision and, today, on World Arthritis Day, our global Janssen team is taking action in advancing science to help those living with rheumatic and musculoskeletal diseases today and in the future.

Read More

October 9th, 2015

Prostate Cancer: Living, Not Just Surviving

By Jane Griffiths, Company Group Chairman, Janssen EMEA and Executive Sponsor, Janssen Sustainability Council

Janssen report focuses on quality of life for prostate cancer survivors

Prostate Cancer: Living, Not Just SurvivingMore than three million men in Europe have prostate cancer and almost half of them have lived with the disease for five years or more, according to European Commission. Advances in the management of prostate cancer means that more patients are beating the disease and looking ahead at what it means to live as a survivor.

To bring focus to the issues facing prostate cancer survivors, the team at Janssen recently launched the Prostate Cancer: Living, not Just Surviving report, summarizing findings of a pan-European survey of prostate cancer patients, caregivers and healthcare professionals looking at the physical, emotional and social impact of prostate cancer. Some key findings in the report include:[i]

  • Fatigue (66%) has the biggest negative impact on patients reporting chronic physical effects from the disease, over disability and pain (41% and 22% respectively)
  • Prostate cancer patients are more likely to worry about intimacy problems (54%) than dying (36%), however nearly two-thirds (62%) of patients are not willing to talk about such intimacy problems with their partner
  • In prostate cancer patients:
    • 80% are unable to do activities they used to enjoy before diagnosis
    • 85% are unable to be intimate with their partner following diagnosis
  • Only 14 percent of healthcare professionals feel that they have sufficient resources to address these types of quality of life issues

This launch is the culmination of more than two years’ work, involving many patient organisations from across Europe.

Read More

October 9th, 2015

From Couch Potato to IRONMAN: How I Did it – With Type 1 Diabetes

By Casey Boren

Casey Boren by the ocean pre-race

My First Tri

When I was growing up, my parents owned a running store, and I swore I’d never be a runner. Call it rebellion.

Instead, I grew up, got married and was running computer systems for Starbucks. Then, in September of 2003, when I was 33, my wife’s brother and sister and some friends came out to Seattle to do a fun little mini-triathlon. They weren’t extreme athletes by a longshot: This was just a half-mile swim, a 15-mile bike ride, and a 5K run, which is about 3.2 miles.

Of course, at that point in life, my favorite activity was pretty much watching ESPN. But these guys were so enthusiastic about this race, and they kept encouraging me to do it with them. I actually don’t quite know how it all happened. They were like “Come on, man, you can do it!” And I was like, “I haven’t trained!” A few hours (and a few beers) later, they had me convinced.

When I say I was unprepared, I’m not kidding: I didn’t even own a bike. Well, strike that: I had a cute, little hipster-cruiser bike. I didn’t have running shoes – just cross-trainers. I had no idea what I was getting into.

Read More

October 9th, 2015

Preventing the Next Ebola Outbreak

By Paul Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson

Vaccine Volunteer Idrissa Kamara

Early this January, just six weeks after Johnson & Johnson announced the acceleration of an Ebola vaccine program in response to the world’s deadliest Ebola outbreak, a team of us flew to Sierra Leone to begin exploring the possibility of conducting a clinical trial there.

That same week, Sierra Leone had recorded almost 250 cases of Ebola, and since March 2014, almost 10,000 cases and nearly 3,000 deaths. The devastation we saw on that first trip was horrifying.

Today, Ebola no longer terrorizes the people of Liberia, Guinea and Sierra Leone, other African countries or the rest of the world. And just this week, since March 2014, the World Health Organization reported no new cases.

This is the result of dedicated work and collaboration by health care workers, non-profit organizations, civil societies and foundations, local and foreign governments and the private sector who are now focused on the hard work of recovery and on the lessons learned for preparedness.

The threat of Ebola has abated for the moment, but we have another threat we must watch out for – complacency.

Without a treatment, licensed vaccine, or cure for Ebola, we risk once again a lack of preparedness for the next time an Ebola outbreak happens.

Read More

October 8th, 2015

An Asia Pacific Roadmap for Partnership in Mental Health

By Ai Hua Ong, President, One Johnson & Johnson South East Asia


I recently had the opportunity to attend the fifth annual Asia Pacific Economic Cooperation (APEC) High Level Meeting on Health & the Economy in Cebu, Philippines where I joined a panel discussion on mobilizing a cross-sectoral approach to improving health awareness and services delivery that involves government, business and non-government organizations.

Over the last two decades, we have seen an exponential growth in the number of multi-sectoral collaborations and public-private partnerships tackling some of the world’s deadliest infectious diseases, such as HIV, Ebola and Tuberculosis. It was clear from the panel discussion that multi-sectoral approaches are expanding to areas of healthcare previously thought of as sector-siloed, including health awareness, service delivery and system strengthening. Today multi-sectoral approaches have the potential to reconfigure the landscape, driving innovation wherever health-creation opportunities exist, and there is a need for more such cooperation in the Asia-Pacific region.

One area in need of urgent attention is mental illness, which imposes a substantial burden on individuals and their loved ones, as well as employers, governments and society as a whole. The economic burden of mental illness is significant and research has shown that these diseases have a high impact on economies through losses in productivity and total care costs.

Read More

October 5th, 2015

Policies that Underestimate NCDs Could Blunt Economic Growth in Asia

By Kris Sterkens, Company Group Chairman, Janssen, the pharmaceutical companies of Johnson & Johnson, Asia Pacific

A new report from the EcoShifting Landscape of HC in AP_Page_1nomist – The Shifting Landscape of Healthcare in Asia Pacific confirms that people in our region are living longer, but not necessarily healthier, with overburdened, provider-led healthcare systems that lack comprehensive strategies to address emerging non-communicable diseases (NCDs) such as cancer, diabetes and mental illness.

We provided a grant for the development of this independent research report, which examines whether current health policies in Australia, China, India, Japan and South Korea are coping with the sharp rise of NCDs while these countries continue to tackle an existing burden of infectious diseases, such as tuberculosis and hepatitis.

There is a quote in the report by Professor Aikichi Iwamoto, chair of Japan’s National HIV Surveillance Committee, who notes that one difficulty in dealing with the HIV/AIDS epidemic in much of Asia is that “health systems in many countries are more adjusted to acute infections where people are cured by antimicrobials in five days.”

This accurately captures the history of a region that has endured deadly emergency outbreaks of viruses and influenzas for more than a century, most recently with SARS and Avian Flu.

Read More